I. K. Kuramoto

707 citations
20 papers · 525 indexed · h-index 11

I. K. Kuramoto

19 papers receiving 510 citations

Peers

I. K. Kuramoto
Comparison fields: 5 of 57
  • Hepatology 448
  • Epidemiology 323
  • Infectious Diseases 171
  • Small Animals 39
  • Molecular Biology 26
Replace María Luisa Mateos with:
María Luisa Mateos Spain
M Lafrenz Germany
Kurt H. Chau United States
L. F. Barker United States
Mikihiro Yunoki Japan
Iwao Ariyama Japan
Antigoni Katsoulidou Greece
S. M. Bowyer South Africa
Yasunobu Kawakami Japan
E. D'Hondt Spain
I. K. Kuramoto relative to María Luisa Mateos Spain María Luisa Mateos's profile →
Citations per field
00.5×1.6×
María Luisa Mateos · 1×
Citations per year

Countries citing papers authored by I. K. Kuramoto

Since Specialization
Citations

This map shows the geographic impact of I. K. Kuramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. K. Kuramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. K. Kuramoto more than expected).

Fields of papers citing papers by I. K. Kuramoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. K. Kuramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. K. Kuramoto. The network helps show where I. K. Kuramoto may publish in the future.

Co-authorship network of co-authors of I. K. Kuramoto

This figure shows the co-authorship network connecting the top 25 collaborators of I. K. Kuramoto. A scholar is included among the top collaborators of I. K. Kuramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. K. Kuramoto. I. K. Kuramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 119
3 10
4 2
5 4
6 11
7 41
8 6
9 26
10 3
11 0
12 2
13 4
14 6
15
Seroepidemiology of viral infections among intravenous drug users in northern California.
81
16 30
17 68
18 51
19
Hepatitis C in liver transplant recipients.
14
20 43

About I. K. Kuramoto

I. K. Kuramoto is a scholar working on Hepatology, Epidemiology and Virology, having authored 20 papers that have together received 525 indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Hepatology (448 citations), Epidemiology (323 citations) and Infectious Diseases (171 citations). I. K. Kuramoto has collaborated with scholars based in United States, Japan and Portugal. Frequent co-authors include Jerome B. Zeldis, P. V. Holland, Paul V. Holland, Neil M. Flynn, Michael O. Favorov, Craig N. Shapiro, Eric E. Mast, Brett Burkholder, Kathleen Sazama and C A Richards. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026